2000
DOI: 10.1016/s0197-4580(99)00108-6
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
21
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(22 citation statements)
references
References 95 publications
1
21
0
Order By: Relevance
“…FernandezVizarra et al (40) have shown that neuronal NOS protein levels aberrantly increase in AD neurons, whereas neuronal NOS activity in brain lysates is reduced. Increased expression of endothelial NOS in AD is also observed, but is primarily localized to the dystrophic neurites and astrocytes that surround amyloid plaques (11,41). Our quantitative PCR data support the idea that changes in constitutive NOS isoforms are unlikely to adequately compensate for the genetic loss of iNOS.…”
Section: Discussionsupporting
confidence: 74%
“…FernandezVizarra et al (40) have shown that neuronal NOS protein levels aberrantly increase in AD neurons, whereas neuronal NOS activity in brain lysates is reduced. Increased expression of endothelial NOS in AD is also observed, but is primarily localized to the dystrophic neurites and astrocytes that surround amyloid plaques (11,41). Our quantitative PCR data support the idea that changes in constitutive NOS isoforms are unlikely to adequately compensate for the genetic loss of iNOS.…”
Section: Discussionsupporting
confidence: 74%
“…47 The NOS pathway has been implicated in the pathogenesis of Alzheimer's disease (AD), PD, and cerebrovascular disease and stroke, and previous studies have also demonstrated aberrant expression of the NOS3 gene in neurons, glial and endothelial cells in AD brains. [46][47][48] The Glu/Glu genotype at p.(Asp298Glu) (rs1799983; ClinVar pathogenic allele) has been reported as a risk factor for AD in several case-control studies.…”
Section: Discussionmentioning
confidence: 99%
“…Expression of eNOS has been examined in Alzheimer's disease with variable results. 15 One might expect that eNOS deficiency would enhance the phenotype of Alzheimer's disease mice, because of increased APP, BACE1, and A␤ in both neurons and microvessels. Such studies have been reported with iNOS-deficient mice with conflicting results.…”
mentioning
confidence: 99%